Scientific Opinion on the substantiation of health claims related to pectins and reduction of post-prandial glycaemic responses (ID 786), maintenance of normal blood cholesterol concentrations (ID 818) and increase in satiety leading to a reduction in energy intake (ID 4692) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

被引:32
|
作者
Agostoni, Carlo [1 ]
Bresson, Jean-Louis [1 ]
Fairweather-Tait, Susan [1 ]
Flynn, Albert [1 ]
Golly, Ines [1 ]
Korhonen, Harmu [1 ]
Lagiou, Pagona [1 ]
Lovik, Martinus [1 ]
Marchelli, Rosangela [1 ]
Martin, Ambroise [1 ]
Moseley, Bevan [1 ]
Neuhaeuser-Berthold, Monika [1 ]
Przyrembel, Hildegard [1 ]
Salminen, Seppo [1 ]
Sanz, Yolanda [1 ]
Strain, Sean [1 ]
Strobel, Stephan [1 ]
Tetens, Inge [1 ]
Tome, Daniel [1 ]
van Loveren, Hendrik [1 ]
Verhagen, Hans [1 ]
机构
[1] EFSA, Parma, Italy
关键词
Pectins; glycaemic response; cholesterol; satiety; health claims;
D O I
10.2903/j.efsa.2010.1747
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to pectins and reduction of post-prandial glycaemic responses, maintenance of normal blood cholesterol concentrations and increase in satiety leading to a reduction in energy intake. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food constituent that is the subject of the health claims is pectins. The Panel considers that pectins are sufficiently characterised. Reduction of post-prandial glycaemic responses The claimed effect is "reduces the postprandial levels of glucose". The target population is assumed to be individuals willing to reduce their post-prandial glycaemic responses. The Panel considers that reduction of post-prandial glycaemic responses (as long as post-prandial insulinaemic responses are not disproportionally increased) may be a beneficial physiological effect. In weighing the evidence, the Panel took into account the consistency of a post-prandial blood glucose-lowering effect of pectins consumed in foods or meals across the studies considered, and that the mechanism by which pectins could exert the claimed effect is well known. On the basis of the data presented, the Panel concludes that a cause and effect relationship has been established between the consumption of pectins and a reduction of post-prandial glycaemic responses. The Panel considers that, in order to bear the claim, foods should provide at least 10 g of pectins per meal. The target population is adults willing to reduce their post-prandial glycaemic responses. Maintenance of normal blood cholesterol concentrations The claimed effect is "cholesterol maintenance". The target population is assumed to be the general population. The Panel considers that maintenance of normal blood cholesterol concentrations is a beneficial physiological effect. In weighing the evidence, the Panel took into account the consistency of the total and LDL-cholesterol lowering effect of pectins across the studies considered, and that the mechanism by which pectins could exert the claimed effect is well known. On the basis of the data presented, the Panel concludes that a cause and effect relationship has been established between the consumption of pectins and maintenance of normal blood cholesterol concentrations. The Panel considers that, in order to bear the claim, foods should provide at least 6 g per day of pectins in one or more servings. The target population is adults. Increase in satiety leading to a reduction in energy intake The claimed effect is "satiety". The target population is assumed to be the general population. The Panel considers that an increase in satiety leading to a reduction in energy intake, if sustained, might be a beneficial physiological effect. No references were provided from which conclusions could be drawn for the scientific substantiation of the claimed effect. On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the consumption of pectins and a sustained increase in satiety leading to a reduction in energy intake.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Opinion on the substantiation of health claims related to alpha-linolenic acid and maintenance of normal blood cholesterol concentrations (ID 493) and maintenance of normal blood pressure (ID 625) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    Bresson, Jean-Louis
    Flynn, Albert
    Heinonen, Marina
    Hulshof, Karin
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Przyrembel, Hildegard
    Salminen, Seppo
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    van den Berg, Henk
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2009, 7 (10)
  • [22] Scientific Opinion on the substantiation of health claims related to phosphorus and reduction of tiredness and fatigue (ID 323) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2011, 9 (04)
  • [23] Scientific Opinion on the substantiation of health claims related to glycaemic carbohydrates and maintenance of normal brain function (ID 603, 653) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2011, 9 (06)
  • [24] Scientific Opinion on the substantiation of health claims related to sodium bicarbonate and maintenance of normal blood pressure (ID 1404) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhauser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2011, 9 (06)
  • [25] Scientific Opinion on the substantiation of health claims related to intense sweeteners and contribution to the maintenance or achievement of a normal body weight (ID 1136, 1444, 4299), reduction of post-prandial glycaemic responses (ID 4298), maintenance of normal blood glucose concentrations (ID 1221, 4298), and maintenance of tooth mineralisation by decreasing tooth demineralisation (ID 1134, 1167, 1283) pursuant to Article 13( 1) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2011, 9 (06)
  • [27] Scientific Opinion on the substantiation of health claims related to sodium and maintenance of normal muscle function (ID 359) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    -Tait, Susan Fairweather
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhauser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    Van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2011, 9 (06)
  • [28] Scientific Opinion on the substantiation of a health claim related to AlphaGOS (R) and a reduction of post-prandial glycaemic responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjodin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2014, 12 (10)
  • [29] Scientific Opinion on the substantiation of health claims related to resistant starch and reduction of post-prandial glycaemic responses (ID 681), "digestive health benefits" (ID 682) and "favours a normal colon metabolism" (ID 783) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2011, 9 (04)
  • [30] Scientific Opinion on the substantiation of health claims related to alpha-cylcodextrin and reduction of post-prandial glycaemic responses (ID 856, 2926), maintenance or achievement of a normal body weight (ID 2925) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2010, 8 (02)